Your browser doesn't support javascript.
loading
Inhibition of Chikungunya virus early replication by intracellular nanoantibodies targeting nsP2 Epitope Rich Region.
Deng, Qiang; Guo, Zhongmin; Hu, Huan; Li, Qianlin; Zhang, Yingtao; Wang, Jin; Liao, Conghui; Guo, Cheng; Li, Xiaokang; Chen, Zeliang; Lu, Jiahai.
Afiliação
  • Deng Q; One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; NMPA Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, 510080, China; Key Laboratory of Tropical Diseases Control,
  • Guo Z; Laboratory Animal Center, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China; Experimental Animal Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • Hu H; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
  • Li Q; One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; NMPA Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, 510080, China; Key Laboratory of Tropical Diseases Control,
  • Zhang Y; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, 510080, China.
  • Wang J; Department of Pulmonary Medicine, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
  • Liao C; One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; NMPA Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, 510080, China; Key Laboratory of Tropical Diseases Control,
  • Guo C; Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, United States.
  • Li X; One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; NMPA Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, 510080, China; Key Laboratory of Tropical Diseases Control,
  • Chen Z; One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; NMPA Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, 510080, China; Key Laboratory of Tropical Diseases Control,
  • Lu J; One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, China; NMPA Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, 510080, China; Key Laboratory of Tropical Diseases Control,
Antiviral Res ; 208: 105446, 2022 12.
Article em En | MEDLINE | ID: mdl-36270543
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Chikungunya / Febre de Chikungunya Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Chikungunya / Febre de Chikungunya Idioma: En Ano de publicação: 2022 Tipo de documento: Article